Waldenström macroglobulinemia: 2012 update on diagnosis, risk stratification, and management

MA Gertz - American journal of hematology, 2012 - pubmed.ncbi.nlm.nih.gov
Disease overview Waldenström macroglobulinemia (WM) is a lymphoplasmacytic
lymphoma with immunoglobulin M (IgM) monoclonal protein. Clinical features include …

Waldenström macroglobulinemia: 2013 update on diagnosis, risk stratification, and management

MA Gertz - American journal of hematology, 2013 - pubmed.ncbi.nlm.nih.gov
Disease overview Waldenström macroglobulinemia (WM) is a lymphoplasmacytic
lymphoma with immunoglobulin M (IgM) monoclonal protein. Clinical features include …

Waldenström macroglobulinemia: 2011 update on diagnosis, risk stratification, and management

MA Gertz - American journal of hematology, 2011 - Wiley Online Library
Disease overview: Waldenström macroglobulinemia (WM) is a lymphoplasmacytic
lymphoma with immunoglobulin M (IgM) monoclonal protein. Clinical features include …

Waldenström macroglobulinemia: 2017 update on diagnosis, risk stratification, and management

MA Gertz - American journal of hematology, 2017 - Wiley Online Library
Disease Overview: Waldenström macroglobulinemia (WM) is a lymphoplasmacytic
lymphoma with immunoglobulin M (IgM) monoclonal protein. Clinical features include …

Waldenström macroglobulinemia: 2019 update on diagnosis, risk stratification, and management

MA Gertz - American journal of hematology, 2019 - Wiley Online Library
Disease Overview Waldenström macroglobulinemia (WM) is a lymphoplasmacytic
lymphoma with immunoglobulin M (IgM) monoclonal protein. Clinical features include …

Waldenström macroglobulinemia: 2021 update on diagnosis, risk stratification, and management

MA Gertz - American journal of hematology, 2021 - mayoclinic.elsevierpure.com
Abstract Disease Overview: Waldenström macroglobulinemia (WM) is a lymphoplasmacytic
lymphoma with immunoglobulin M (IgM) monoclonal protein. Clinical features include …

Waldenström macroglobulinemia: 2023 update on diagnosis, risk stratification, and management

MA Gertz - American journal of hematology, 2023 - Wiley Online Library
Abstract Disease Overview Waldenström macroglobulinemia (WM) is a lymphoplasmacytic
lymphoma with immunoglobulin M (IgM) monoclonal protein. Clinical features include …

Waldenström macroglobulinemia

A Vijay, MA Gertz - Blood, the Journal of the American Society …, 2007 - ashpublications.org
In the past 36 months, new developments have occurred both in the understanding of the
biology of Waldenström macroglobulinemia (WM) and in therapeutic options for WM. Here …

Waldenström macroglobulinemia: What a hematologist needs to know

P Kapoor, J Paludo, N Vallumsetla, PR Greipp - Blood Reviews, 2015 - Elsevier
Waldenström macroglobulinemia (WM) is a distinct hematologic malignancy characterized
by a lymphoplasmacytic bone marrow infiltration and the presence of immunoglobulin (Ig) M …

Waldenström macroglobulinemia: a review of pathogenesis, current treatment, and future prospects

B Ghafoor, SS Masthan, M Hameed, HH Akhtar… - Annals of …, 2024 - Springer
Waldenström macroglobulinemia (WM) is a chronic B-cell lymphoproliferative disorder
characterized by lymphoplasmacytic cell overgrowth in the bone marrow and increased …